Evidence map›Paper›PMID 36066494›Full record

ArticleChronic obstructive pulmonary diseases (Miami, Fla.)2022

Endurance Time During Constant Work Rate Cycle Ergometry in COPD: Development of an Integrated Database From Interventional Studies.

Richard Casaburi, Debora Merrill, Thomas Dolmage, Judith Garcia-Aymerich, Malin Fageras, Roger Goldstein, Gale Harding, Nancy Kline Leidy, Francois Maltais, Denis O'Donnell and 10 more

Open access · diamondAbstract read
In one paragraph

Article in Chronic obstructive pulmonary diseases (Miami, Fla.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 9 institutions in 5 countries.

Richard CasaburiRehabilitation Clinical Trials Center, Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California, United States.
Debora MerrillCOPD Foundation, Miami, Florida, United States.
Thomas DolmageRespiratory Diagnostic and Evaluation Services and Respiratory Medicine, West Park Healthcare Centre, Toronto, Canada.
Judith Garcia-AymerichISGlobal, Barcelona, Spain.
Malin FagerasBiopharmaceuticals, Respiratory and Immunology, AstraZeneca, Gothenburg Sweden.
Roger GoldsteinDepartment of Medicine and Rehabilitation Science, University of Toronto, Toronto, Canada.
Gale HardingEvidera, Bethesda, Maryland, United States.
Nancy Kline LeidyEvidera, Bethesda, Maryland, United States.
Francois MaltaisUniversité Laval, Quebec, Canada.
Denis O'DonnellRespiratory Investigation Unit, Department of Medicine, Queen's University and Kingston Health Sciences Centre, Kingston, Ontario, Canada.
Janos PorszaszRehabilitation Clinical Trials Center, Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California, United States.
Luis Puente-MaestuHospital General Universitario Gregorio Marañón Universidad, Madrid, Spain.
Stephen RennardDivision of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska, United States.
Frank SciurbaDivision of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, United States.
Martijn A SpruitDepartment of Research and Development, Ciro, Horn and Department of Respiratory Medicine, Maastricht University Medical Cen.
Ruth Tal-SingerCOPD Foundation, Miami, Florida, United States.
Kay TetzlaffBoehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany.
Alex Van't HulDepartment of Respiratory Diseases, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
Ren YuEvidera, Bethesda, Maryland, United States.
Alan HamiltonCOPD Foundation, Miami, Florida, United States.
COPD Foundation · USIthaka Harbors · USBarcelona Institute for Global Health · ESBoehringer Ingelheim (Germany) · DEQueen's University · CARadboud University Medical Center · NLUniversité Laval · CAUniversity of Nebraska Medical Center · USUniversity of Pittsburgh · US

Funding

AstraZenecaBoehringer IngelheimChiesiGlaxoSmithKlineNovartis
6 · The paper itself

Abstract

Introduction: The COPD Biomarkers Qualification Consortium (CBQC) was formed under COPD Foundation management, with the goal of qualifying biomarkers and clinical outcome assessments through established regulatory processes for chronic obstructive pulmonary disease (COPD). Within CBQC, a working group evaluated opportunities for qualification of an exercise endurance measure. In a recent publication ( Methods: We sought participant-level data from published studies incorporating CWRCE as an outcome measure. A literature search screened 2993 publications and identified 553 studies for assessment. Two interventions had sufficient data across studies to warrant data extraction: bronchodilators and rehabilitative exercise training. Investigators were contacted and requested to provide participant-by-participant data from their published studies. Results: The final dataset included data from 8 bronchodilator studies (2166) participants and 15 exercise training studies (3488 participants). The database includes 71 variables per participant, comprising demographic, pulmonary function, and detailed physiologic response data. This paper provides a detailed description of the analysis population, while analysis supporting the validation/qualification process and addressing other scientific questions will be described in subsequent publications.

Indexed as

bronchodilatorclinical outcome assessmentexercise enduranceexercise trainingpatient-centric

Identifiers

PMID36066494
PMCPMC9718584
OpenAlexW4297580789

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.